Definitions of respiratory events in sleep-disordered breathing

Cyclic alternating pattern and positive airway pressure titration

OBJECTIVE

To demonstrate that stability of the upper airway during continuous positive airway pressure (CPAP) titration is influenced by the microstructure of sleep as defined by the cyclic alternating pattern (CAP).

METHODS

Retrospective review of 12 CPAP titration records. The patterns of flow-limitation during CPAP at subtherapeutic pressures were characterized as 'stable' (persistent and non-progressive inspiratory flow limitation) or 'unstable' (progressive increase in inspiratory flow-limitation terminating in an arousal), and continuous periods of at least 10 min were identified. Sleep stage scoring by both conventional Rechtshaffen and Kales criteria and the CAP were done. The relationship between flow type and CAP was determined. Responses to an increase in applied pressure on flow-limitation were noted.

RESULTS

There were a total of 50 periods fulfilling the above criteria, totaling 1113 min of titration time. Thirty periods (757 min, 68% of total) showed a stable flow-limitation pattern. A total of 29/30 periods showing a stable flow pattern during sleep was scored as non-CAP, and only a single 18-min period of stable flow was scored as CAP. A total of 19/20 periods showing an unstable flow pattern was in sleep with CAP characteristics, the exception being a single 14-min period where unstable flow was noted in non-CAP. Flow-limitation was stable and non-progressive or absent during non-CAP, even at less than optimal pressures. This was noted irrespective of the presence or absence of delta sleep as scored by conventional criteria. Pressure increases during non-CAP, when the profile of the inspiratory flow was flattened, never resulted in a discernable change in the flow profile, while at least two-thirds of pressure increments during CAP periods improved flow.

CONCLUSIONS

The microstructure of sleep as determined by CAP and non-CAP have practical implications for manual pressure titration algorithms and research on upper airway physiology during sleep. The appearance of a period of non-CAP, irrespective of conventionally scored delta sleep, may falsely suggest that the CPAP is optimal or close to it. Large increases in non-CAP that may be seen during a titration night can reduce the window of opportunity for titration. Increases in CPAP should be avoided in non-CAP.

Continuous positive airway pressure: new generations

Automatic positive airway pressure devices are the most technologically advanced positive airway pressure devices available for use in OSA. Although heterogeneous, they have in common the ability to detect and respond to changes in upper airway resistance. Data cannot necessarily be extrapolated from one device to another, and the field is rapidly advancing. Most studies of APAP have been performed in a supervised setting, or patients have been carefully selected to have a high likelihood of OSA uncomplicated by disorders such as alveolar hypoventilation or central apnea or technical problems such as mask leaks. Studies of APAP for the diagnosis of OSA have shown that APAP can diagnose severe OSA effectively, but the diagnosis of mild-moderate OSA is less reliable. APAP devices also can be effective therapy for selected patients with OSA, with overall similar results to conventional fixed CPAP in terms of respiratory disturbances, sleep quality, nocturnal oxygenation, and daytime sleepiness and performance, with less known or other long-term outcomes. In most studies, mean treatment pressures are lower, without change in side effect profile. Compliance and preference with APAP are similar to or somewhat better than CPAP in most studies. APAP also can be used in an attended setting to titrate an effective pressure for use in long-term conventional CPAP therapy, also with similar results to CPAP in many patients. APAP devices are more expensive than CPAP devices, but the cost may be outweighed if a group of patients who can be diagnosed, treated, or titrated safely in the unattended setting can be identified. Although diagnostic and therapeutic algorithms for APAP have been proposed, the best candidates for this modality must be defined better.

Effect of the new Medicare guideline on patient qualification for positive airway pressure therapy

BACKGROUND

New Medicare criteria for prescribing continuous positive airway pressure (CPAP) recognize hypopnea as a sleep disordered breathing event. In so doing, hypopnea was redefined as requiring a 4% oxygen desaturation. The criteria omit electroencephalogram (EEG) arousals from the definition. This study was designed to assess how the new Medicare guideline changes CPAP eligibility.

METHODS

Polysomnograms from 113 consecutive patients with obstructive sleep apnea were scored using both a definition for hypopnea that considered EEG arousals and the new Medicare definition that does not consider EEG arousal. CPAP eligibility was evaluated and compared.

RESULTS

Sixteen percent of all patients and 41% of patients apnea+hypopnea index </=20 did not qualify for CPAP under the new Medicare guidelines.

CONCLUSIONS

The new Medicare guidelines may underestimate OSA event occurrence and thereby deny CPAP therapy to many patients.